Analysis of Retroviral Vector Insertion Sites after T-Cell Directed Gene Therapy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V104.11.289.289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Emerging drugs for rarer chronic lymphoid leukemias

  2008cites this paper
• Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic Malignancies

  2007cites this paper
• Clinical activity of tipifarnib in hematologic malignancies

  2007cites this paper
• Emerging drugs for chronic lymphocytic leukaemia

  2006cites this paper
• Emerging drugs in chronic myelogenous leukaemia

  2006cites this paper
• Evolving molecular therapy for chronic myeloid leukaemia—are we on target?

  2005cites this paper
• Development of the farnesyltransferase inhibitor tipifarnib for therapy of hematologic malignancies.

  2005cites this paper